Head-to-head comparison
Hims & Hers vs StackMD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Desk Score
StackMD is a New York telehealth platform (Medical 360 HC PLLC) selling compounded semaglutide and tirzepatide, both formulated with B12 and glycine, alongside NAD+, sermorelin and other longevity peptides.
$199 (see conditions) sema · $299 (see conditions) tirz · Verified August 2026
Marked down on: ⛔ Four different semaglutide figures across two pages in August 2026 — $125 and $125/month on the home page, $199 and $99/month on the product page — under a header that promises 'Transparent Pricing'
Hims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 69/100 (C) for StackMD. StackMD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Hims & Hers
79/100
C+
StackMD
69/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Hims & Hers | StackMD |
|---|---|---|
| Semaglutide | $199/mo$199/mo | $199see conditions$199 on the product page (the home card says $125 and the same page's own block says $99/mo; no billing cycle stated at checkout, compounded) |
| Tirzepatide | Not listed on Hims & Hers's site | $299see conditions$299 on the product page (the home card says $199; no billing cycle stated at checkout, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a familiar consumer-brand app experience and don't need tirzepatide. | A patient who has already chosen StackMD for another reason and is prepared to discover the real charge at checkout — not for anyone shopping on price. |
| Desk Score | 79/100C+ | 69/100C |
The verdict
Desk pick — Hims & HersHims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 69/100 (C) for StackMD. StackMD still holds its ground where its strengths line up with yours.
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Choose StackMD if…
A patient who has already chosen StackMD for another reason and is prepared to discover the real charge at checkout — not for anyone shopping on price.
$199 (see conditions) sema · $299 (see conditions) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Hims & Hers · StackMD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Hims & Hers
- CoreAge Rx vs StackMD
- Hims & Hers vs Ondra Health
- HealthRX vs StackMD
- Hims & Hers vs Vaylen
- Breeze Meds vs StackMD
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.